Richard K. Prins - Dec 9, 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
Dec 9, 2024
Transactions value $
-$242,502
Form type
4
Date filed
12/11/2024, 08:28 PM
Previous filing
Nov 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $195K +10K +32.82% $19.52 40.5K Dec 9, 2024 Direct
transaction AMPH Common Stock Sale -$438K -10K -24.71% $43.77 30.5K Dec 9, 2024 Direct F1
transaction AMPH Common Stock Gift $0 -410 -1.35% $0.00 30.1K Dec 9, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00 0 Dec 9, 2024 Common Stock 10K $19.52 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $43.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2 Shares subject to the option are fully vested and immediately exercisable.